Glycoconjugates and related molecules in human vascular endothelial cells

International Journal of Vascular Medicine

Volumn 2013, Issue , 2013, Pages

  Sasaki, Norihiko ^a   Toyoda, Masashi ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIGLYCAN; C REACTIVE PROTEIN; CHONDROITIN SULFATE; DECORIN; DERMATAN SULFATE; FUCOSE; GALECTIN; GLUCURONOSYLTRANSFERASE; GLYCAN; GLYCOCONJUGATE; GLYCOSPHINGOLIPID; GLYPICAN; HEPARAN SULFATE; HYALURONIC ACID; INTERLEUKIN 1; INTERLEUKIN 15; LACTOSYLCERAMIDE; MANNOSE; MIGLUSTAT; N ACETYLGLUCOSAMINE; PERLECAN; PROTEOGLYCAN; SMALL INTERFERING RNA; SYNDECAN 2; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2; VEROTOXIN; VERSICAN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ATHEROGENESIS; BASEMENT MEMBRANE; BLOOD VESSEL PERMEABILITY; BREAST CANCER; CARBOHYDRATE ANALYSIS; CARDIOVASCULAR RISK; CELL ADHESION; CELL DIFFERENTIATION; CELL JUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; DIABETIC RETINOPATHY; DYNAMICS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; FOCAL ADHESION; GENE EXPRESSION; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERGLYCEMIA; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; MONOLAYER CULTURE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEIN TARGETING; REVIEW; TUMOR GROWTH; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM; WOUND HEALING;

EID: 84885630392     PISSN: 20902824     EISSN: 20902832     Source Type: Journal    
DOI: 10.1155/2013/963596     Document Type: Review

References (80)

1. Li Y.-S. J., Haga J. H., Chien S. J., Molecular basis of the effects of shear stress on vascular endothelial cells. Journal of Biomechanics 2005 38 10 1949 1971 2-s2.0-23444452042 10.1016/j.jbiomech.2004.09.030 (Pubitemid 41111740)
2. Aird W. C., Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circulation Research 2007 100 2 158 173 2-s2.0-33846798106 10.1161/01.RES.0000255691.76142.4a (Pubitemid 46208717)
3. Essentials of Glycobiology 2008 2nd Cold Spring Harbor, NY, USA Cold Spring Harbor Laboratory Press
4. Geyer H., Geyer R., Odenthal-Schnittler M., Schnittler H.-J., Characterization of human vascular endothelial cadherin glycans. Glycobiology 1999 9 9 915 925 2-s2.0-0032860174 10.1093/glycob/9.9.915 (Pubitemid 29435865)
5. Chacko B. K., Scott D. W., Chandler R. T., Patel R. P., Endothelial surface N -glycans mediate monocyte adhesion and are targets for anti-inflammatory effects of peroxisome proliferator-activated receptor γ ligands. Journal of Biological Chemistry 2011 286 44 38738 38747 2-s2.0-80055076022 10.1074/jbc.M111.247981
6. García-Vallejo J. J., van Dijk W., van Het Hof B., van Die I., Engelse M. A., van Hinsbergh V. W. M., Gringhuis S. I., Activation of human endothelial cells by tumor necrosis factor- α results in profound changes in the expression of glycosylation-related genes. Journal of Cellular Physiology 2006 206 1 203 210 2-s2.0-28444485987 10.1002/jcp.20458 (Pubitemid 41740733)
7. Peng Y., Li J., Geng M., The glycan profile of endothelial cells in the present of tumor-conditioned medium and potential roles of β -1,6-GlcNAc branching on HUVEC conformation. Molecular and Cellular Biochemistry 2010 340 1-2 143 152 2-s2.0-77954424603 10.1007/s11010-010-0411-z
8. Scott D. W., Chen J., Chacko B. K., Role of endothelial N -glycan mannose residues in monocyte recruitment during atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 8 e51 e59 10.1161/ATVBAHA.112.253203
9. Lingwood C. A., Glycosphingolipid functions. Cold Spring Harbor Perspectives in Biology 2011 3 7 1 26 2-s2.0-80455162364
10. Gillard B. K., Jones M. A., Marcus D. M., Glycosphingolipids of human umbilical vein endothelial cells and smooth muscle cells. Archives of Biochemistry and Biophysics 1987 256 2 435 445 2-s2.0-0023236887 (Pubitemid 17128519)
11. Gillard B. K., Jones M. A., Turner A. A., Lewis D. E., Marcus D. M., Interferon- γ alters expression of endothelial cell-surface glycosphingolipids. Archives of Biochemistry and Biophysics 1990 279 1 122 129 2-s2.0-0025268087 10.1016/0003-9861(90)90471-A (Pubitemid 20149782)
12. van de Kar N. C. A. J., Monnens L. A. H., Karmali M. A., van Hinsbergh V. W. M., Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood 1992 80 11 2755 2764 2-s2.0-0026454927
13. Eisenhauer P. B., Chaturvedi P., Fine R. E., Ritchie A. J., Pober J. S., Cleary T. G., Newburg D. S., Tumor necrosis factor alpha increases human cerebral endothelial cell Gb3 and sensitivity to Shiga toxin. Infection and Immunity 2001 69 3 1889 1894 2-s2.0-0035112195 10.1128/IAI.69.3.1889-1894.2001 (Pubitemid 32187651)
14. Schweppe C. H., Bielaszewska M., Pohlentz G., Friedrich A. W., Büntemeyer H., Alexander Schmidt M., Kim K. S., Peter-Katalinić J., Karch H., Müthing J., Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity. Glycoconjugate Journal 2008 25 4 291 304 2-s2.0-41149089223 10.1007/s10719-007-9091-7
15. Rajesh M., Kolmakova A., Chatterjee S., Novel role of lactosylceramide in vascular endothelial growth factor-mediated angiogenesis in human endothelial cells. Circulation Research 2005 97 8 796 804 2-s2.0-26844440360 10.1161/01.RES.0000185327.45463.A8 (Pubitemid 41447130)
16. Kolmakova A., Rajesh M., Zang D., Pili R., Chatterjee S., VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo. Glycoconjugate Journal 2009 26 5 547 558 2-s2.0-68949117986 10.1007/s10719-008-9206-9
17. Mukherjee P., Faber A. C., Shelton L. M., Baek R. C., Chiles T. C., Seyfried T. N., Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a. Journal of Lipid Research 2008 49 5 929 938 2-s2.0-50049110689 10.1194/jlr.R800006-JLR200
18. Dasgupta S., Yanagisawa M., Rrishnamurthy K., Liour S. S., Yu R. K., Tumor necrosis factor- α up-regulates glucuronosyltransferase gene expression in human brain endothelial cells and promotes T-cell adhesion. Journal of Neuroscience Research 2007 85 5 1086 1094 2-s2.0-34147200206 10.1002/jnr.21214 (Pubitemid 46580349)
19. Dasgupta S., Silva J., Wang G., Yu R. K., Sulfoglucuronosyl paragloboside is a ligand for T cell adhesion: regulation of sulfoglucuronosyl paragloboside expression via nuclear factor B signaling. Journal of Neuroscience Research 2009 87 16 3591 3599 2-s2.0-71249122269 10.1002/jnr.22153
20. Dasgupta S., Wang G., Yu R. K., Sulfoglucuronosyl paragloboside promotes endothelial cell apoptosis in inflammation: elucidation of a novel glycosphingolipid-signaling pathway. Journal of Neurochemistry 2011 119 4 749 759 2-s2.0-80054799069 10.1111/j.1471-4159.2011.07483.x
21. Iozzo R. V., Matrix proteoglycans: from molecular design to cellular function. Annual Review of Biochemistry 1998 67 609 652 2-s2.0-0031657808 10.1146/annurev.biochem.67.1.609 (Pubitemid 28411140)
22. Schaefer L., Schaefer R. M., Proteoglycans: from structural compounds to signaling molecules. Cell and Tissue Research 2010 339 1 237 246 2-s2.0-72449147268 10.1007/s00441-009-0821-y
23. Klein N. J., Shennan G. I., Heyderman R. S., Levin M., Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils. Journal of Cell Science 1992 102, part 4 821 832 2-s2.0-0026737738
24. Devaraj S., Yun J.-M., Adamson G., Galvez J., Jialal I., C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction. Cardiovascular Research 2009 84 3 479 484 2-s2.0-70849095298 10.1093/cvr/cvp249
25. Reine T. M., Kusche-Gullberg M., Feta A., Jenssen T., Kolset S. O., Heparan sulfate expression is affected by inflammatory stimuli in primary human endothelial cells. Glycoconjugate Journal 2012 29 1 67 76 2-s2.0-84857371248 10.1007/s10719-011-9365-y
26. Norgard-Sumnicht K., Varki A., Endothelial heparan sulfate proteoglycans that bind to L-selectin have glucosamine residues with unsubstituted amino groups. Journal of Biological Chemistry 1995 270 20 12012 12024 2-s2.0-0029043456 10.1074/jbc.270.20.12012
27. Robinson M. J., Tessier P., Poulsom R., Hogg N., The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells. Journal of Biological Chemistry 2002 277 5 3658 3665 2-s2.0-0036479102 10.1074/jbc.M102950200 (Pubitemid 34953239)
28. Xu D., Young J., Song D., Esko J. D., Heparan sulfate is essential for high mobility group protein 1 (HMGB1) signaling by the receptor for advanced glycation end products (RAGE). Journal of Biological Chemistry 2011 286 48 41736 41744 2-s2.0-82355181520 10.1074/jbc.M111.299685
29. Vogt A. M., Barragan A., Chen Q., Kironde F., Spillmann D., Wahlgren M., Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1 α domain of PfEMP1. Blood 2003 101 6 2405 2411 2-s2.0-0037443518 10.1182/blood-2002-07-2016 (Pubitemid 36302089)
30. Narita K., Staub J., Chien J., Meyer K., Bauer M., Friedl A., Ramakrishnan S., Shridhar V., HSulf-1 inhibits angiogenesis and tumorigenesis in vivo. Cancer Research 2006 66 12 6025 6032 2-s2.0-33745728172 10.1158/0008-5472.CAN-05-3582
31. Ferreras C., Rushton G., Cole C. L., Endothelial heparan sulfate 6- O -sulfation levels regulate angiogenic responses of endothelial cells to fibroblast growth factor 2 and vascular endothelial growth factor. Journal of Biological Chemistry 2012 287 43 36132 36146
32. Wang T., Ward Y., Tian L., Lake R., Guedez L., Stetler-Stevenson W. G., Kelly K., CD97, an adhesion receptor on inflammatory cells, stimulates angiogenesis through binding integrin counterreceptors on endothelial cells. Blood 2005 105 7 2836 2844 2-s2.0-15944418189 10.1182/blood-2004-07-2878 (Pubitemid 40446277)
33. Estess P., Nandi A., Mohamadzadeh M., Siegelman M. H., Interleukin 15 induces endothelial hyaluronan expression in vitro and promotes activated T cell extravasation through a CD44-dependent pathway in vivo. Journal of Experimental Medicine 1999 190 1 9 19 2-s2.0-0033526776 10.1084/jem.190.1.9 (Pubitemid 29330119)
34. Vigetti D., Genasetti A., Karousou E., Viola M., Moretto P., Clerici M., Deleonibus S., De Luca G., Hascall V. C., Passi A., Proinflammatory cytokines induce hyaluronan synthesis and monocyte adhesion in human endothelial cells through hyaluronan synthase 2 (HAS2) and the nuclear factor- B (NF- B) pathway. Journal of Biological Chemistry 2010 285 32 24639 24645 2-s2.0-77955290281 10.1074/jbc.M110.134536
35. Gouverneur M., Spaan J. A. E., Pannekoek H., Fontijn R. D., Vink H., Fluid shear stress stimulates incorporation of hyaluronan into endothelial cell glycocalyx. American Journal of Physiology-Heart and Circulatory Physiology 2006 290 1 H458 H462 2-s2.0-33644808696 10.1152/ajpheart.00592.2005
36. Maroski J., Vorderwülbecke B. J., Fiedorowicz K., Da Silva-Azevedo L., Siegel G., Marki A., Pries A. R., Zakrzewicz A., Shear stress increases endothelial hyaluronan synthase 2 and hyaluronan synthesis especially in regard to an atheroprotective flow profile. Experimental Physiology 2011 96 9 977 986 2-s2.0-80051944499 10.1113/expphysiol.2010.056051
37. Whitelock J. M., Graham L. D., Melrose J., Murdoch A. D., Iozzo R. V., Anne Underwood P., Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells. Matrix Biology 1999 18 2 163 178 2-s2.0-0032893101 10.1016/S0945-053X(99)00014-1 (Pubitemid 29229702)
38. Knox S., Melrose J., Whitelock J., Electrophoretic, biosensor, and bioactivity analyses of perlecans of different cellular origins. Proteomics 2001 1 12 1534 1541 (Pubitemid 33587911)
39. Knox S., Merry C., Stringer S., Melrose J., Whitelock J., Not all perlecans are created equal. Interactions with fibroblast growth factor (FGF) 2 and FGF receptors. Journal of Biological Chemistry 2002 277 17 14657 14665 2-s2.0-0037177869 10.1074/jbc.M111826200 (Pubitemid 34952534)
40. Vogl-Willis C. A., Edwards I. J., High-glucose-induced structural changes in the heparan sulfate proteoglycan, perlecan, of cultured human aortic endothelial cells. Biochimica et Biophysica Acta 2004 1672 1 36 45 2-s2.0-1642619054 10.1016/j.bbagen.2004.02.005 (Pubitemid 38410966)
41. Zhang W., Chuang Y.-J., Swanson R., Li J., Seo K., Leung L., Lau L. F., Olson S. T., Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells. Blood 2004 103 4 1185 1191 2-s2.0-0842264049 10.1182/blood-2003-08-2920 (Pubitemid 38168626)
42. Zhang W., Chuang Y.-J., Jin T., Swanson R., Xiong Y., Leung L., Olson S. T., Antiangiogenic antithrombin induces global changes in the gene expression profile of endothelial cells. Cancer Research 2006 66 10 5047 5055 2-s2.0-33744911983 10.1158/0008-5472.CAN-05-4449 (Pubitemid 43844925)
43. Sakai K., Nakamura T., Matsumoto K., Nakamura T., Angioinhibitory action of NK4 involves impaired extracellular assembly of fibronectin mediated by Perlecan-NK4 association. Journal of Biological Chemistry 2009 284 33 22491 22499 2-s2.0-69249088890 10.1074/jbc.M109.025148
44. Béchard D., Gentina T., Delehedde M., Scherpereel A., Lyon M., Aumercier M., Vazeux R., Richet C., Degand P., Jude B., Janin A., Fernig D. G., Tonnel A.-B., Lassalle P., Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. Journal of Biological Chemistry 2001 276 51 48341 48349 2-s2.0-0035930590
45. Abid M. R., Yi X., Yano K., Shih S.-C., Aird W. C., Vascular endocan is preferentially expressed in tumor endothelium. Microvascular Research 2006 72 3 136 145 2-s2.0-33751106440 10.1016/j.mvr.2006.05.010 (Pubitemid 44767770)
46. Delehedde M., Devenyns L., Maurage C. A., Vivès R. R., Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan. International Journal of Cell Biology 2013 2013 11 705027 10.1155/2013/705027
47. Strazynski M., Eble J. A., Kresse H., Schönherr E., Interleukin (IL)-6 and IL-10 induce decorin mRNA in endothelial cells, but interaction with fibrillar collagen is essential for its translation. Journal of Biological Chemistry 2004 279 20 21266 21270 2-s2.0-2442676736 10.1074/jbc.M309782200 (Pubitemid 38656532)
48. Schönherr E., Sunderkötter C., Iozzo R. V., Schaefer L., Decorin, a novel player in the insulin-like growth factor system. Journal of Biological Chemistry 2005 280 16 15767 15772 2-s2.0-18144431289 10.1074/jbc.M500451200 (Pubitemid 40616696)
49. Fiedler L. R., Schönherr E., Waddington R., Niland S., Seidler D. G., Aeschlimann D., Eble J. A., Decorin regulates endothelial cell motility on collagen I through activation of insulin-like growth factor I receptor and modulation of α 2 β 1 integrin activity. Journal of Biological Chemistry 2008 283 25 17406 17415 2-s2.0-47749104114 10.1074/jbc.M710025200
50. Fiedler L. R., Eble J. A., Decorin regulates endothelial cell-matrix interactions during angiogenesis. Cell Adhesion and Migration 2009 3 1 3 6 2-s2.0-67049142568 10.4161/cam.3.1.7275
51. Cattaruzza S., Schiappacassi M., Ljungberg-Rose Å., Spessotto P., Perissinotto D., Mörgelin M., Mucignat M. T., Colombatti A., Perris R., Distribution of PG-M/versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro. Journal of Biological Chemistry 2002 277 49 47626 47635 2-s2.0-0346037291 10.1074/jbc.M206521200 (Pubitemid 36159284)
52. Nelimarkka L., Kainulainen V., Schönherr E., Moisander S., Jortikka M., Lammi M., Elenius K., Jalkanen M., Järveläinen H., Expression of small extracellular chondroitin/dermatan sulfate proteoglycans is differentially regulated in human endothelial cells. Journal of Biological Chemistry 1997 272 19 12730 12737 2-s2.0-0030911737 10.1074/jbc.272.19.12730 (Pubitemid 27203372)
53. Gengrinovitch S., Berman B., David G., Witte L., Neufeld G., Ron D., Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165. Journal of Biological Chemistry 1999 274 16 10816 10822 2-s2.0-0033574278 10.1074/jbc.274.16.10816 (Pubitemid 29191062)
54. Qiao D., Meyer K., Friedl A., Glypican-1 stimulates Skp2 autoinduction loop and G1/S transition in endothelial cells. Journal of Biological Chemistry 2012 287 8 5898 5909 2-s2.0-84857279342 10.1074/jbc.M111.325282
55. Gharagozlian S., Borrebæk J., Henriksen T., Omsland T. K., Shegarfi H., Kolset S. O., Effect of hyperglycemic condition on proteoglycan secretion in cultured human endothelial cells. European Journal of Nutrition 2006 45 7 369 375 2-s2.0-33750365586 10.1007/s00394-006-0608-9 (Pubitemid 44630731)
56. Nunes S. S., Outeiro-Bernstein M. A. F., Juliano L., Vardiero F., Nader H. B., Woods A., Legrand C., Morandi V., Syndecan-4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1. Journal of Cellular Physiology 2008 214 3 828 837 2-s2.0-38449103435 10.1002/jcp.21281 (Pubitemid 351224228)
57. Noguer O., Villena J., Lorita J., Vilaró S., Reina M., Syndecan-2 downregulation impairs angiogenesis in human microvascular endothelial cells. Experimental Cell Research 2009 315 5 795 808 2-s2.0-59849088721 10.1016/j.yexcr.2008.11.016
58. Beauvais D. M., Ell B. J., McWhorter A. R., Rapraeger A. C., Syndecan-1 regulates α v β 3 and α v β 5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor. Journal of Experimental Medicine 2009 206 3 691 705 2-s2.0-63449129028 10.1084/jem.20081278
59. Cooper D. N. W., Galectinomics: finding themes in complexity. Biochimica et Biophysica Acta 2002 1572 2-3 209 231 2-s2.0-0037136416 10.1016/S0304- 4165(02)00310-0 (Pubitemid 35246346)
60. Cooper D. N. W., Barondes S. H., God must love galectins; he made so many of them. Glycobiology 1999 9 10 979 984 2-s2.0-0032875554 10.1093/glycob/9.10. 979 (Pubitemid 29473954)
61. Yang R.-Y., Rabinovich G. A., Liu F.-T., Galectins: structure, function and therapeutic potential. Expert Reviews in Molecular Medicine 2008 10 e17 2-s2.0-45449112374 10.1017/S1462399408000719 (Pubitemid 351850788)
62. Baum L. G., Seilhamer J. J., Pang M., Levine W. B., Beynon D., Berlinger J. A., Synthesis of an endogeneous lectin, galectin-1, by human endothelial cells is up-regulated by endothelial cell activation. Glycoconjugate Journal 1995 12 1 63 68 2-s2.0-0028987368 10.1007/BF00731870
63. Ishikawa A., Imaizumi T., Yoshida H., Nishi N., Nakamura T., Hirashima M., Satoh K., Double-stranded RNA enhances the expression of galectin-9 in vascular endothelial cells. Immunology and Cell Biology 2004 82 4 410 414 2-s2.0-4344663402 10.1111/j.0818-9641.2004.01248.x (Pubitemid 39141764)
64. Thijssen V. L., Hulsmans S., Griffioen A. W., The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells. The American Journal of Pathology 2008 172 2 545 553 2-s2.0-39549084700 10.2353/ajpath.2008.070938 (Pubitemid 351282039)
65. Alam S., Li H., Margariti A., Martin D., Zampetaki A., Habi O., Cockerill G., Hu Y., Xu Q., Zeng L., Galectin-9 protein expression in endothelial cells is positively regulated by histone deacetylase 3. Journal of Biological Chemistry 2011 286 51 44211 44217 2-s2.0-83755181625 10.1074/jbc.M111.242289
66. Glinsky V. V., Glinsky G. V., Rittenhouse-Olson K., Huflejt M. E., Glinskii O. V., Deutscher S. L., Quinn T. P., The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Research 2001 61 12 4851 4857 2-s2.0-0035874890 (Pubitemid 32691901)
67. Rabinovich G. A., Cumashi A., Bianco G. A., Ciavardelli D., Iurisci I., D'Egidio M., Piccolo E., Tinari N., Nifantiev N., Iacobelli S., Synthetic lactulose amines: novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis. Glycobiology 2006 16 3 210 220 2-s2.0-33144454670 10.1093/glycob/cwj056 (Pubitemid 43264687)
68. Markowska A. I., Jefferies K. C., Panjwani N., Galectin-3 protein modulates cell surface expression and activation of vascular endothelial Growth factor receptor 2 in human endothelial cells. Journal of Biological Chemistry 2011 286 34 29913 29921 2-s2.0-80051930613 10.1074/jbc.M111.226423
69. Parish C. R., Freeman C., Hulett M. D., Heparanase: a key enzyme involved in cell invasion. Biochimica et Biophysica Acta 2001 1471 3 M99 M108 2-s2.0-0035091164 10.1016/S0304-419X(01)00017-8 (Pubitemid 32206686)
70. Vlodavsky I., Friedmann Y., Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. Journal of Clinical Investigation 2001 108 3 341 347 2-s2.0-0034904048 10.1172/JCI200113662 (Pubitemid 32730777)
71. Godder K., Vlodavsky I., Eldor A., Weksler B. B., Haimovitz-Freidman A., Fuks Z., Heparanase activity in cultured endothelial cells. Journal of Cellular Physiology 1991 148 2 274 280 2-s2.0-0025873762 (Pubitemid 21910151)
72. Yuan L., Hu J., Luo Y., Upregulation of heparanase in high-glucose-treated endothelial cells promotes endothelial cell migration and proliferation and correlates with Akt and extracellular-signal-regulated kinase phosphorylation. Molecular Vision 2012 18 1684 1695
73. Rao G., Ding H. G., Huang W., Le D., Maxhimer J. B., Oosterhof A., van Kuppevelt T., Lum H., Lewis E. J., Reddy V., Prinz R. A., Xu X., Reactive oxygen species mediate high glucose-induced heparanase-1 production and heparan sulphate proteoglycan degradation in human and rat endothelial cells: a potential role in the pathogenesis of atherosclerosis. Diabetologia 2011 54 6 1527 1538 2-s2.0-80052521778 10.1007/s00125-011-2110-z
74. Achyuthan K. E., Achyuthan A. M., Comparative enzymology, biochemistry and pathophysiology of human exo- α -sialidases (neuraminidases). Comparative Biochemistry and Physiology B 2001 129 1 29 64 2-s2.0-0035047041 10.1016/S1096-4959(01)00372-4 (Pubitemid 32401124)
75. Monti E., Preti A., Venerando B., Borsani G., Recent development in mammalian sialidase molecular biology. Neurochemical Research 2002 27 7-8 649 663 2-s2.0-0036694820 10.1023/A:1020276000901
76. Cross A. S., Hyun S. W., Miranda-Ribera A., NEU1 and NEU3 sialidase activity expressed in human lung microvascular endothelia: NEU1 restrains endothelial cell migration, whereas NEU3 does not. Journal of Biological Chemistry 2012 287 19 15966 15980
77. Tran-Lundmark K., Tran P.-K., Paulsson-Berne G., Fridén V., Soininen R., Tryggvason K., Wight T. N., Kinsella M. G., Borén J., Hedin U., Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation. Circulation Research 2008 103 1 43 52 2-s2.0-48049100574 10.1161/CIRCRESAHA.108.172833
78. Huang F., Thompson J. C., Wilson P. G., Aung H. H., Rutledge J. C., Tannock L. R., Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development. Journal of Lipid Research 2008 49 3 521 530 2-s2.0-42949151068 10.1194/jlr.M700329-JLR200
79. Folkman J., Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine 1995 1 1 27 31 2-s2.0-0028929803
80. Fuster M. M., Wang L., Endothelial heparan sulfate in angiogenesis. Progress in Molecular Biology and Translational Science 2010 93 179 212 2-s2.0-77958168593 10.1016/S1877-1173(10)93009-3